1. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway
   Wei Gao et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. JNK ‐dependent gene regulatory circuitry governs mesenchymal fate
   Sanjeeb Kumar Sahu et al, 2015, The EMBO Journal CrossRef
3. The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma
   C Hermanns et al, 2017, Oncogene CrossRef
4. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer
   Jipeng Yin et al, 2019, Human Pathology CrossRef
5. Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma
   Wen-Jie Fan et al, 2023, South Asian Journal of Cancer CrossRef
6. The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis
   Yanli Liu et al, 2020, Aging CrossRef
7. Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma
   Mingyan Xu et al, 2023, Cancers CrossRef
8. Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
   Weibo Chen et al, 2019, FEBS Open Bio CrossRef
9. Community Structure Reveals Biologically Functional Modules in MEF2C Transcriptional Regulatory Network
   Sergio A. Alcalá-Corona et al, 2016, Frontiers in Physiology CrossRef
10. Multi-phenotypic Role of Serum Response Factor in the Gastrointestinal System
    Seungil Ro, 2016, Journal of Neurogastroenterology and Motility CrossRef
11. Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation
    Yan Feng et al, 2018, Molecular Medicine Reports CrossRef
12. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
    Jiang Chen et al, 2015, Cancer Letters CrossRef
13. Loss of serum response factor induces microRNA-mediated apoptosis in intestinal smooth muscle cells
    C Park et al, 2015, Cell Death & Disease CrossRef
14. Serum response factor‐cofactor interactions and their implications in disease
    John Oloche Onuh et al, 2021, The FEBS Journal CrossRef
15. Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
    Constanze Mittermeier et al, 2020, Cells CrossRef
16. Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells
    Tian-yi Zhou et al, 2016, Scientific Reports CrossRef
17. PIN1 in hepatocellular carcinoma is associated with TP53 gene status
    Jun Sang Bae et al, 2016, Oncology Reports CrossRef
18. I131 reinforces antitumor activity of metuximab by reversing epithelial–mesenchymal transition via VEGFR‐2 signaling in hepatocellular carcinoma
    Lu Wu et al, 2018, Genes to Cells CrossRef
19. Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activity
    Sandra Voringer et al, 2020, Oncogene CrossRef
20. Emerging role for the Serum Response Factor (SRF) as a potential therapeutic target in cancer
    Haleema Azam et al, 2022, Expert Opinion on Therapeutic Targets CrossRef